The goals of this SELECTBIO workshop, Antibodies in drug discovery, are to fully explore the latest developments in the designing and engineering of antibodies as it relates to the burgeoning field of biotherapeutics. Engineering challenges and techniques, new technologies and business hurdles when developing antibodies, and the latest developments in discovery for autoimmune and infectious diseases will be addressed. Attendees will benefit from the expert knowledge of academic and industry leaders who are pushing the boundaries of antibody discovery, whilst networking with the technology providers who are enabling them to do so.
Christian Klein, Expert Scientist/Head, Roche Glycart AG
Paul Insel, Professor, University of California San Diego
John McCafferty,Co-Founder, Director and CEO, IONTAS
You can present your research on a poster while attending the meeting. Poster Submission Deadline: 19 January 2016.
Contact for more information:
|Tel: +44 (0) 1787 314956|
This content is blocked. Accept cookies to view the content.